Two Formula Foods for Special Medical Purposes for Rare Diseases Gain Registration Approval

2025-01-22 / Read about 0 minute

Author：小编

Recently, two domestically produced formula foods specifically designed for children with rare diseases such as phenylketonuria, methylmalonic acidemia, and propionic acidemia have successfully obtained registration approval. This marks a significant breakthrough in the field, ending the previous absence of domestic production in this category. Notably, these two products are the inaugural batch to be greenlit under the State Administration for Market Regulation's priority review and approval process. This expedited process has dramatically shortened the review timeline, cutting it down from 60 working days to just 20, with on-site inspections and sampling tests being given top priority.

Previous page：GuoXin Technology Forecasts Net Loss of 177 Millio...

Next page：Chaoyan Stock Soars Over 370% on ChiNext Debut

Return to List

Hot Reading

2 day ago

Nalini Priya Uppari Established AI DOC Co-pilot at Enterprise Innovation with AI for Governance and Compliance as Her Organization's Core Business Focus

2 day ago

GPT-5 is supposed to be nicer now

2 day ago

Sustaining AI Performance: Engineering Reliable GPU Systems

2 day ago

Evidence Grows That GPT-5 Is a Bit of a Dud